EVP, Chief Commercial Officer of Arena Pharmaceuticals Inc (30-Year Financial, Insider Trades) Robert Lisicki (insider trades) sold 30,000 shares of ARNA on 08/04/2020 at an average price of $63.34 a share. The total sale was $1.9 million.
Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. Arena Pharmaceuticals Inc has a market cap of $3.66 billion; its shares were traded at around $64.63 with and P/S ratio of 582.27. GuruFocus has detected 4 severe warning signs with Arena Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- EVP, Chief Commercial Officer Robert Lisicki sold 30,000 shares of ARNA stock on 08/04/2020 at the average price of $63.34. The price of the stock has increased by 2.04% since.
- EVP, Head of R&D, and CMO Christopher Cabell sold 13,000 shares of ARNA stock on 07/15/2020 at the average price of $68. The price of the stock has decreased by 4.96% since.
For the complete insider trading history of ARNA, click here
.
